Check out CRN's latest press releases in our feed, or search for your topics of interest. Members of the media, learn more here about working with CRN for science-based information for your reporting.
JULY 27, 2023 — CRN today provided written testimony to the U.S. House of Representatives Committee on Oversight and Accountability, Subcommittee on Health Care and Financial Services, asking that Congress demand FDA complete the work Congress directed the agency to do under the 2018 Farm Bill by permitting CBD and other hemp-derived cannabinoids to be lawfully marketed as dietary supplements using the appropriate safeguards found in the existing law.
Read more
Read more